Pfizer Eyeing Bid for Bayer?

Bayer’s share price rose sharply last week on market speculation over a possible takeover bid for the company from Pfizer. Both companies declined to comment on the speculation. Purchasing Bayer would be complicated for Pfizer because Pfizer would need to break Bayer up to get to the Bayer HealthCare business, analysts say. Bayer’s other businesses are Bayer CropScience and Bayer...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers